⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
AVIR News
Atea Pharmaceuticals, Inc. Common Stock
Atea Pharmaceuticals Presents New Data Supporting the Fixed-Dose Combination of Bemnifosbuvir and Ruzasvir as a Potential Best-in-Class Regimen for Treatment of Hepatitis C Virus Infection at The Liver Meeting® 2025
globenewswire.com
AVIR
Atea Pharmaceuticals to Host Third Quarter 2025 Financial Results and Business Update Conference Call on November 12, 2025
globenewswire.com
AVIR
Atea Pharmaceuticals to Present New Data Supporting Combination of Bemnifosbuvir and Ruzasvir as Potential Best-in-Class Regimen for Treatment of Hepatitis C Virus Infection at The Liver Meeting® 2025
globenewswire.com
AVIR
AvAir Enters into Long-Term Aircraft Asset Management Agreement with XAero for Multi-Aircraft Teardown Program
prnewswire.com
AVIR
AvAir Enters into Long-Term Aircraft Asset Management Agreement with XAero for Multi-Aircraft Teardown Program
prnewswire.com
AVIR
BA